Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-04

FDA Approved: IRBESARTAN — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original generic application for irbesartan (IRBESARTAN) by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)